Format

Send to

Choose Destination
See comment in PubMed Commons below
Hematol Oncol Clin North Am. 2009 Dec;23(6):1163-75. doi: 10.1016/j.hoc.2009.08.008.

Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective platelet production.

Author information

1
Division of Molecular and Experimental Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. robtmcmillan@sbcglobal.net

Abstract

Chronic immune thrombocytopenia (ITP) is an autoimmune disorder manifested by immune-mediated platelet destruction and suppression of platelet production. Chronic ITP characteristically has an insidious onset, usually requires therapy, and is most commonly seen in adults. The diagnosis of chronic ITP is one of exclusion and is based on the American Society of Hematology Guidelines: The patient's history, physical examination, and peripheral blood film must be consistent with the diagnosis and other causes of thrombocytopenia must be ruled out. This article reviews the role of antiplatelet autoantibody in adult chronic ITP.

PMID:
19932426
DOI:
10.1016/j.hoc.2009.08.008
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center